{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T19:18:42Z","timestamp":1711999122699},"reference-count":109,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T00:00:00Z","timestamp":1641340800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T00:00:00Z","timestamp":1641340800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Z Rheumatol"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s00393-021-01135-8","type":"journal-article","created":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T12:04:28Z","timestamp":1641384268000},"page":"14-21","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Spondyloarthritiden im Kindes- und Erwachsenenalter"],"prefix":"10.1007","volume":"81","author":[{"given":"Toni","family":"Hospach","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerd","family":"Horneff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denis","family":"Poddubnyy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,1,5]]},"reference":[{"issue":"2","key":"1135_CR1","first-page":"390","volume":"31","author":"RE Petty","year":"2004","unstructured":"Petty\u00a0RE et\u00a0al (2004) International league of associations for rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J\u00a0Rheumatol 31(2):390\u2013392","journal-title":"J Rheumatol"},{"issue":"1","key":"1135_CR2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12969-018-0238-9","volume":"16","author":"M Goirand","year":"2018","unstructured":"Goirand\u00a0M et al (2018) Clinical features of children with enthesitis-related juvenile idiopathic arthritis \/ juvenile spondyloarthritis followed in a\u00a0French tertiary care pediatric rheumatology centre. Pediatr Rheumatol Online J 16(1):21","journal-title":"Pediatr. Rheumatol. Online J."},{"issue":"2","key":"1135_CR3","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3899\/jrheum.180168","volume":"46","author":"A Martini","year":"2019","unstructured":"Martini\u00a0A et\u00a0al (2019) Toward new classification criteria for juvenile idiopathic arthritis: first steps, pediatric rheumatology international trials organization international consensus. J\u00a0Rheumatol 46(2):190\u2013197","journal-title":"J Rheumatol"},{"issue":"10","key":"1135_CR4","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1136\/annrheumdis-2020-217769","volume":"79","author":"D Porter","year":"2020","unstructured":"Porter\u00a0D, Basu\u00a0N, Siebert\u00a0S (2020) Classification criteria: time for a\u00a0rethink? Ann Rheum Dis 79(10):1264\u20131266","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"1135_CR5","doi-asserted-by":"crossref","first-page":"iv6","DOI":"10.1093\/rheumatology\/keaa250","volume":"59","author":"D Poddubnyy","year":"2020","unstructured":"Poddubnyy\u00a0D (2020) Classification vs diagnostic criteria: the challenge of diagnosing axial spondyloarthritis. Rheumatology (Oxford) 59(4):iv6\u2013iv17","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"1135_CR6","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1002\/art.10444","volume":"46","author":"K Minden","year":"2002","unstructured":"Minden\u00a0K et al (2002) Long-term outcome in patients with juvenile idiopathic arthritis. Arthritis Rheum 46(9):2392\u20132401","journal-title":"Arthritis Rheum"},{"issue":"9","key":"1135_CR7","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1002\/acr.21688","volume":"64","author":"U Kiltz","year":"2012","unstructured":"Kiltz\u00a0U et al (2012) Do patients with non-radiographic axial spondylarthritis differ from patients with ankylosing spondylitis? Arthritis Care Res (Hoboken) 64(9):1415\u20131422","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"3","key":"1135_CR8","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/art.24483","volume":"60","author":"M Rudwaleit","year":"2009","unstructured":"Rudwaleit\u00a0M et\u00a0al (2009) The early disease stage in axial spondylarthritis: results from the german spondyloarthritis inception cohort. Arthritis Rheum 60(3):717\u2013727","journal-title":"Arthritis Rheum"},{"issue":"1","key":"1135_CR9","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/1529-0131(200101)44:1<180::AID-ANR24>3.0.CO;2-K","volume":"44","author":"M Dougados","year":"2001","unstructured":"Dougados\u00a0M et al (2001) Efficacy of celecoxib, a\u00a0cyclooxygenase 2\u2011specific inhibitor, in the treatment of ankylosing spondylitis: a\u00a0six-week controlled study with comparison against placebo and against a\u00a0conventional nonsteroidal antiinflammatory drug. Arthritis Rheum 44(1):180\u2013185","journal-title":"Arthritis Rheum"},{"issue":"4","key":"1135_CR10","first-page":"735","volume":"24","author":"KS Gomez","year":"1997","unstructured":"Gomez\u00a0KS et\u00a0al (1997) Juvenile onset ankylosing spondylitis\u2014more girls than we thought? J\u00a0Rheumatol 24(4):735\u2013737","journal-title":"J Rheumatol"},{"issue":"10089","key":"1135_CR11","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0140-6736(16)31591-4","volume":"390","author":"J Sieper","year":"2017","unstructured":"Sieper\u00a0J, Poddubnyy\u00a0D (2017) Axial spondyloarthritis. Lancet 390(10089):73\u201384","journal-title":"Lancet"},{"issue":"10","key":"1135_CR12","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1002\/art.1780401015","volume":"40","author":"MA Brown","year":"1997","unstructured":"Brown\u00a0MA et\u00a0al (1997) Susceptibility to ankylosing spondylitis in twins: the role of genes, HLA, and the environment. Arthritis Rheum 40(10):1823\u20131828","journal-title":"Arthritis Rheum"},{"issue":"1","key":"1135_CR13","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00393-019-00708-y","volume":"79","author":"J Sieper","year":"2020","unstructured":"Sieper\u00a0J, Poddubnyy\u00a0D (2020) Pathogenesis of spondylarthritis : relevance for treatment. Z\u00a0Rheumatol 79(1):5\u201312","journal-title":"Z Rheumatol"},{"issue":"1","key":"1135_CR14","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13075-017-1297-x","volume":"19","author":"S Gmuca","year":"2017","unstructured":"Gmuca\u00a0S et al (2017) Multicenter inception cohort of enthesitis-related arthritis: variation in disease characteristics and treatment approaches. Arthritis Res Ther 19(1):84","journal-title":"Arthritis Res Ther"},{"issue":"9","key":"1135_CR15","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1002\/acr.20508","volume":"63","author":"PF Weiss","year":"2011","unstructured":"Weiss\u00a0PF et al (2011) Enthesitis in an inception cohort of enthesitis-related arthritis. Arthritis Care Res 63(9):1307\u20131312","journal-title":"Arthritis Care Res"},{"issue":"1","key":"1135_CR16","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1546-0096-10-14","volume":"10","author":"R Burgos-Vargas","year":"2012","unstructured":"Burgos-Vargas\u00a0R (2012) The assessment of the spondyloarthritis international society concept and criteria for the classification of axial spondyloarthritis and peripheral spondyloarthritis: a critical appraisal for the pediatric rheumatologist. Pediatr Rheumatol Online\u00a0J 10(1):14","journal-title":"Pediatr Rheumatol Online J"},{"issue":"5","key":"1135_CR17","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.3899\/jrheum.111031","volume":"39","author":"HA Chen","year":"2012","unstructured":"Chen\u00a0HA et al (2012) Clinical, functional, and radiographic differences among juvenile-onset, adult-onset, and late-onset ankylosing spondylitis. J\u00a0Rheumatol 39(5):1013\u20131018","journal-title":"J Rheumatol"},{"issue":"2","key":"1135_CR18","first-page":"290","volume":"30","author":"I Olivieri","year":"2012","unstructured":"Olivieri\u00a0I et al (2012) Low frequency of axial involvement in southern Italian Caucasian children with HLA-B27 positive juvenile onset undifferentiated spondyloarthritis. Clin Exp Rheumatol 30(2):290\u2013296","journal-title":"Clin Exp Rheumatol"},{"issue":"9","key":"1135_CR19","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1002\/acr.20508","volume":"63","author":"PF Weiss","year":"2011","unstructured":"Weiss\u00a0PF et al (2011) Enthesitis in an inception cohort of enthesitis-related arthritis. Arthritis Care Res (Hoboken) 63(9):1307\u20131312","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"6","key":"1135_CR20","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1002\/art.1780380618","volume":"38","author":"R Burgos-Vargas","year":"1995","unstructured":"Burgos-Vargas\u00a0R, Vazquez-Mellado\u00a0J (1995) The early clinical recognition of juvenile-onset ankylosing spondylitis and its differentiation from juvenile rheumatoid arthritis. Arthritis Rheum 38(6):835\u2013844","journal-title":"Arthritis Rheum"},{"issue":"2","key":"1135_CR21","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/acr.22665","volume":"68","author":"PF Weiss","year":"2016","unstructured":"Weiss\u00a0PF et\u00a0al (2016) Assessment of sacroiliitis at diagnosis of juvenile spondyloarthritis by radiography, magnetic resonance imaging, and clinical examination. Arthritis Care Res 68(2):187\u2013194","journal-title":"Arthritis Care Res"},{"issue":"11","key":"1135_CR22","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.3899\/jrheum.100014","volume":"37","author":"ML Stoll","year":"2010","unstructured":"Stoll\u00a0ML et\u00a0al (2010) Spondyloarthritis in a\u00a0pediatric population: risk factors for sacroiliitis. J\u00a0Rheumatol 37(11):2402\u20132408","journal-title":"J Rheumatol"},{"issue":"11","key":"1135_CR23","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1002\/art.22181","volume":"54","author":"B Flat\u00f8","year":"2006","unstructured":"Flat\u00f8\u00a0B et al (2006) Long-term outcome and prognostic factors in enthesitis-related arthritis: a\u00a0case-control study. Arthritis Rheum 54(11):3573\u20133582","journal-title":"Arthritis Rheum"},{"issue":"11","key":"1135_CR24","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.3899\/jrheum.100090","volume":"37","author":"I Pagnini","year":"2010","unstructured":"Pagnini\u00a0I et al (2010) Early predictors of juvenile sacroiliitis in enthesitis-related arthritis. J\u00a0Rheumatol 37(11):2395\u20132401","journal-title":"J Rheumatol"},{"issue":"5","key":"1135_CR25","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/acr.22191","volume":"66","author":"L Terslev","year":"2014","unstructured":"Terslev\u00a0L et\u00a0al (2014) Defining enthesitis in spondyloarthritis by ultrasound: results of a\u00a0Delphi process and of a\u00a0reliability reading exercise. Arthritis Care Res (Hoboken) 66(5):741\u2013748","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"1135_CR26","doi-asserted-by":"publisher","first-page":"e001450","DOI":"10.1136\/rmdopen-2020-001450","volume":"7","author":"C Lopez-Medina","year":"2021","unstructured":"Lopez-Medina\u00a0C et al (2021) Prevalence and distribution of peripheral musculoskeletal manifestations in spondyloarthritis including psoriatic arthritis: results of the worldwide, cross-sectional ASAS-PerSpA study. RMD Open 7(1):e1450. https:\/\/doi.org\/10.1136\/rmdopen-2020-001450","journal-title":"RMD Open"},{"issue":"6","key":"1135_CR27","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1093\/rheumatology\/kem053","volume":"46","author":"A Heiligenhaus","year":"2007","unstructured":"Heiligenhaus\u00a0A et al (2007) Prevalence and complications of uveitis in juvenile idiopathic arthritis in a\u00a0population-based nation-wide study in Germany: suggested modification of the current screening guidelines. Rheumatology (Oxford) 46(6):1015\u20131019","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"1135_CR28","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s12969-020-00463-4","volume":"18","author":"A Marino","year":"2020","unstructured":"Marino\u00a0A et\u00a0al (2020) Juvenile spondyloarthritis: focus on uveitis. Pediatr Rheumatol Online J 18(1):70","journal-title":"Pediatr. Rheumatol. Online J."},{"issue":"191085","key":"1135_CR29","first-page":"191085","volume":"15","author":"K Walscheid","year":"2020","unstructured":"Walscheid\u00a0K et al (2020) Enthesitis-related arthritis: prevalence and complications of associated uveitis in children and adolescents from a\u00a0population-based nation-wide study in Germany. J\u00a0Rheumatol 15(191085):191085","journal-title":"J Rheumatol"},{"issue":"4","key":"1135_CR30","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.ophtha.2003.07.011","volume":"111","author":"D Monnet","year":"2004","unstructured":"Monnet\u00a0D et al (2004) Ophthalmic findings and frequency of extraocular manifestations in patients with HLA-B27 uveitis: a\u00a0study of 175\u00a0cases. Ophthalmology 111(4):802\u2013809","journal-title":"Ophthalmology"},{"key":"1135_CR31","doi-asserted-by":"crossref","first-page":"1759720x2095173","DOI":"10.1177\/1759720X20951733","volume":"12","author":"J Rademacher","year":"2020","unstructured":"Rademacher\u00a0J, Poddubnyy\u00a0D, Pleyer\u00a0U (2020) Uveitis in spondyloarthritis. Ther Adv Musculoskelet Dis 12:1759720x20951733","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"9","key":"1135_CR32","first-page":"1567","volume":"20","author":"H Mielants","year":"1993","unstructured":"Mielants\u00a0H et\u00a0al (1993) Gut inflammation in children with late onset pauciarticular juvenile chronic arthritis and evolution to adult spondyloarthropathy\u2014a prospective study. J\u00a0Rheumatol 20(9):1567\u20131572","journal-title":"J Rheumatol"},{"key":"1135_CR33","doi-asserted-by":"crossref","first-page":"1759720x2097261","DOI":"10.1177\/1759720X20972610","volume":"12","author":"I Redeker","year":"2020","unstructured":"Redeker\u00a0I et al (2020) The impact of extra-musculoskeletal manifestations on disease activity, functional status, and treatment patterns in patients with axial spondyloarthritis: results from a\u00a0nationwide population-based study. Ther Adv Musculoskelet Dis 12:1759720x20972610","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"1","key":"1135_CR34","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12969-020-00433-w","volume":"18","author":"T Giani","year":"2020","unstructured":"Giani\u00a0T et\u00a0al (2020) Usefulness of magnetic resonance enterography in detecting signs of sacroiliitis in young patients with inflammatory bowel disease. Pediatr Rheumatol Online\u00a0J 18(1):42","journal-title":"Pediatr Rheumatol Online J"},{"issue":"10","key":"1135_CR35","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.3899\/jrheum.110508","volume":"38","author":"ML Stoll","year":"2011","unstructured":"Stoll\u00a0ML, Punaro\u00a0M, Patel\u00a0AS (2011) Fecal calprotectin in children with the enthesitis-related arthritis subtype of juvenile idiopathic arthritis. J\u00a0Rheumatol 38(10):2274\u20132275","journal-title":"J Rheumatol"},{"key":"1135_CR36","doi-asserted-by":"crossref","first-page":"1759720x2097591","DOI":"10.1177\/1759720X20975915","volume":"12","author":"K Meier","year":"2020","unstructured":"Meier\u00a0K et\u00a0al (2020) Skin manifestations in spondyloarthritis. Ther Adv Musculoskelet Dis 12:1759720x20975915","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"6","key":"1135_CR37","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1093\/rheumatology\/kez457","volume":"59","author":"J Feld","year":"2020","unstructured":"Feld\u00a0J et\u00a0al (2020) Is axial psoriatic arthritis distinct from ankylosing spondylitis with and without concomitant psoriasis? Rheumatology (Oxford) 59(6):1340\u20131346","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"1135_CR38","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1136\/ard.2009.110767","volume":"68","author":"M Rudwaleit","year":"2009","unstructured":"Rudwaleit\u00a0M et\u00a0al (2009) Defining active sacroiliitis on magnetic resonance imaging (MRI) for classification of axial spondyloarthritis: a\u00a0consensual approach by the ASAS\/OMERACT MRI group. Ann Rheum Dis 68(10):1520\u20131527","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"1135_CR39","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1136\/annrheumdis-2019-215589","volume":"78","author":"WP Maksymowych","year":"2019","unstructured":"Maksymowych\u00a0WP et\u00a0al (2019) MRI lesions in the sacroiliac joints of patients with spondyloarthritis: an update of definitions and validation by the ASAS MRI working group. Ann Rheum Dis 78(11):1550\u20131558","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"1135_CR40","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1136\/annrheumdis-2019-215553","volume":"79","author":"X Baraliakos","year":"2020","unstructured":"Baraliakos\u00a0X et al (2020) Frequency of MRI changes suggestive of axial spondyloarthritis in the axial skeleton in a\u00a0large population-based cohort of individuals aged \u300845\u00a0years. Ann Rheum Dis 79(2):186\u2013192","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"1135_CR41","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1136\/annrheumdis-2020-217232","volume":"79","author":"WP Maksymowych","year":"2020","unstructured":"Maksymowych\u00a0WP et\u00a0al (2020) Central reader evaluation of MRI scans of the sacroiliac joints from the ASAS classification cohort: discrepancies with local readers and impact on the performance of the ASAS criteria. Ann Rheum Dis 79(7):935\u2013942","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"1135_CR42","first-page":"1127","volume":"38","author":"T Witte","year":"2020","unstructured":"Witte\u00a0T et\u00a0al (2020) IgA antibodies against CD74 are associated with structural damage in the axial skeleton in patients with axial spondyloarthritis. Clin Exp Rheumatol 38(6):1127\u20131131","journal-title":"Clin Exp Rheumatol"},{"issue":"11","key":"1135_CR43","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1007\/s00247-016-3657-0","volume":"46","author":"JF Rieter","year":"2016","unstructured":"Rieter\u00a0JF et al (2016) The many shades of enhancement: timing of post-gadolinium images strongly influences the scoring of juvenile idiopathic arthritis wrist involvement on MRI. Pediatr Radiol 46(11):1562\u20131567","journal-title":"Pediatr Radiol"},{"issue":"7","key":"1135_CR44","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s00247-012-2575-z","volume":"43","author":"LS Ording Muller","year":"2013","unstructured":"Ording Muller\u00a0LS et al (2013) MRI of the wrist in juvenile idiopathic arthritis: erosions or normal variants? A prospective case-control study. Pediatr Radiol 43(7):785\u2013795","journal-title":"Pediatr Radiol"},{"issue":"6","key":"1135_CR45","first-page":"1236","volume":"29","author":"S Brophy","year":"2002","unstructured":"Brophy\u00a0S et\u00a0al (2002) The natural history of ankylosing spondylitis as defined by radiological progression. J\u00a0Rheumatol 29(6):1236\u20131243","journal-title":"J Rheumatol"},{"issue":"6","key":"1135_CR46","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1136\/annrheumdis-2013-203887","volume":"74","author":"U Weber","year":"2015","unstructured":"Weber\u00a0U et al (2015) Does spinal MRI add incremental diagnostic value to MRI of the sacroiliac joints alone in patients with non-radiographic axial spondyloarthritis? Ann Rheum Dis 74(6):985\u2013992","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"1135_CR47","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/acr.22201","volume":"66","author":"K Vendhan","year":"2014","unstructured":"Vendhan\u00a0K et al (2014) Inflammatory changes of the lumbar spine in children and adolescents with enthesitis-related arthritis: magnetic resonance imaging findings. Arthritis Care Res (Hoboken) 66(1):40\u201346","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"2","key":"1135_CR48","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.rdc.2020.01.003","volume":"46","author":"PF Weiss","year":"2020","unstructured":"Weiss\u00a0PF, Roth\u00a0J (2020) Juvenile-versus adult-onset spondyloarthritis: similar, but different. Rheum Dis Clin North Am 46(2):241\u2013257","journal-title":"Rheum Dis Clin North Am"},{"issue":"6","key":"1135_CR49","doi-asserted-by":"publisher","first-page":"101570","DOI":"10.1016\/j.berh.2020.101570","volume":"34","author":"D Windschall","year":"2020","unstructured":"Windschall\u00a0D, Malattia\u00a0C (2020) Ultrasound imaging in paediatric rheumatology. Best Pract Res Clin Rheumatol 34(6):101570. https:\/\/doi.org\/10.1016\/j.berh.2020.101570","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"6","key":"1135_CR50","doi-asserted-by":"publisher","first-page":"101596","DOI":"10.1016\/j.berh.2020.101596","volume":"34","author":"PF Weiss","year":"2020","unstructured":"Weiss\u00a0PF, Chauvin\u00a0NA (2020) Imaging in the diagnosis and management of axial spondyloarthritis in children. Best Pract Res Clin Rheumatol 34(6):101596. https:\/\/doi.org\/10.1016\/j.berh.2020.101596","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"6","key":"1135_CR51","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1002\/acr.20444","volume":"63","author":"S Jousse-Joulin","year":"2011","unstructured":"Jousse-Joulin\u00a0S et al (2011) Ultrasonography for detecting enthesitis in juvenile idiopathic arthritis. Arthritis Care Res (Hoboken) 63(6):849\u2013855","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"2","key":"1135_CR52","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/art.39458","volume":"68","author":"AS Kehl","year":"2016","unstructured":"Kehl\u00a0AS, Corr\u00a0M, Weisman Review\u00a0MH (2016) Enthesitis: new insights into pathogenesis, diagnostic modalities, and treatment. Arthritis Rheumatol 68(2):312\u2013322","journal-title":"Arthritis Rheumatol"},{"issue":"12","key":"1135_CR53","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/j.crad.2015.09.003","volume":"70","author":"N Herregods","year":"2015","unstructured":"Herregods\u00a0N et\u00a0al (2015) Diagnostic value of MRI features of sacroiliitis in juvenile spondyloarthritis. Clin Radiol 70(12):1428\u20131438","journal-title":"Clin Radiol"},{"issue":"8","key":"1135_CR54","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s00393-020-00838-8","volume":"79","author":"U Kiltz","year":"2020","unstructured":"Kiltz\u00a0U et al (2020) Is it possible to delegate medical services to qualified nurses specialized in rheumatology when evaluating patients with suspicion of ankylosing spondylitis?-Results of the PredAS study. Z\u00a0Rheumatol 79(8):729\u2013736. https:\/\/doi.org\/10.1007\/s00393-020-00838-8","journal-title":"Z Rheumatol"},{"issue":"9","key":"1135_CR55","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s11926-020-00924-5","volume":"22","author":"D Poddubnyy","year":"2020","unstructured":"Poddubnyy\u00a0D, Sieper\u00a0J (2020) Treatment of axial spondyloarthritis: what does the future hold? Curr Rheumatol Rep 22(9):47","journal-title":"Curr Rheumatol Rep"},{"issue":"3","key":"1135_CR56","doi-asserted-by":"crossref","first-page":"618","DOI":"10.3899\/jrheum.150659","volume":"43","author":"CE Althoff","year":"2016","unstructured":"Althoff\u00a0CE et al (2016) Comparison of clinical examination versus whole-body magnetic resonance imaging of enthesitis in patients with early axial spondyloarthritis during 3 years of continuous etanercept treatment. J\u00a0Rheumatol 43(3):618\u2013624","journal-title":"J Rheumatol"},{"issue":"1","key":"1135_CR57","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1136\/ard.2010.138594","volume":"70","author":"P Machado","year":"2011","unstructured":"Machado\u00a0P et al (2011) Ankylosing spondylitis disease activity score (ASDAS): defining cut-off values for disease activity states and improvement scores. Ann Rheum Dis 70(1):47\u201353","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"1135_CR58","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1136\/ard.62.2.127","volume":"62","author":"L Heuft-Dorenbosch","year":"2003","unstructured":"Heuft-Dorenbosch\u00a0L et al (2003) Assessment of enthesitis in ankylosing spondylitis. Ann Rheum Dis 62(2):127\u2013132","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"1135_CR59","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1136\/ard.2007.084244","volume":"68","author":"WP Maksymowych","year":"2009","unstructured":"Maksymowych\u00a0WP et\u00a0al (2009) Development and validation of the spondyloarthritis research consortium of Canada (SPARCC) enthesitis index. Ann Rheum Dis 68(6):948\u2013953","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"1135_CR60","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s00393-019-0678-8","volume":"79","author":"I Redeker","year":"2020","unstructured":"Redeker\u00a0I et\u00a0al (2020) Cost of illness in axial spondylarthritis for patients with and without tumor necrosis factor inhibitor treatment: results of a\u00a0routine data analysis. Z\u00a0Rheumatol 79(1):85\u201394","journal-title":"Z Rheumatol"},{"issue":"1","key":"1135_CR61","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/art.39456","volume":"68","author":"PF Weiss","year":"2016","unstructured":"Weiss\u00a0PF, Vossough\u00a0A, Chauvin\u00a0NA (2016) Reply. Arthritis Rheumatol 68(1):263\u2013264","journal-title":"Arthritis Rheumatol"},{"issue":"5","key":"1135_CR62","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.semarthrit.2020.07.018","volume":"50","author":"F Proft","year":"2020","unstructured":"Proft\u00a0F et al (2020) Comparison of an online self-referral tool with a\u00a0physician-based referral strategy for early recognition of patients with a\u00a0high probability of axial spa. Semin Arthritis Rheum 50(5):1015\u20131021","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"1135_CR63","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13075-020-02157-4","volume":"22","author":"PF Weiss","year":"2020","unstructured":"Weiss\u00a0PF et\u00a0al (2020) Spondyloarthritis research consortium of Canada sacroiliac joint inflammation and structural scores: change score reliability and recalibration utility in children. Arthritis Res Ther 22(1):58","journal-title":"Arthritis Res Ther"},{"key":"1135_CR64","first-page":"1","volume":"29","author":"A Marino","year":"2020","unstructured":"Marino\u00a0A et\u00a0al (2020) Pharmacotherapy for juvenile spondyloarthritis: an overview of the available therapies. Expert Opin Pharmacother 29:1\u20138","journal-title":"Expert Opin Pharmacother"},{"issue":"8","key":"1135_CR65","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1002\/art.39145","volume":"67","author":"G Horneff","year":"2015","unstructured":"Horneff\u00a0G et al (2015) Efficacy and safety of etanercept in enthesitis-related arthritis juvenile idiopathic arthritis: results from a\u00a0phase 3 randomized double-blind study. Arthritis Rheumatol 67(8):2240\u20132249. https:\/\/doi.org\/10.1002\/art.39145","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"1135_CR66","first-page":"424","volume":"32","author":"B Hugle","year":"2014","unstructured":"Hugle\u00a0B et al (2014) Long-term outcome of anti-tumor necrosis factor alpha blockade in the treatment of juvenile spondyloarthritis. Clin Exp Rheumatol 32(3):424\u2013431","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"1135_CR67","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00393-019-00707-z","volume":"79","author":"U Kiltz","year":"2020","unstructured":"Kiltz\u00a0U, Braun\u00a0J (2020) Current treatment of axial spondylarthritis : clinical efficacy. Z\u00a0Rheumatol 79(1):13\u201322","journal-title":"Z Rheumatol"},{"issue":"4","key":"1135_CR68","doi-asserted-by":"crossref","first-page":"665","DOI":"10.3899\/jrheum.141001","volume":"42","author":"S Rohekar","year":"2015","unstructured":"Rohekar\u00a0S et\u00a0al (2015) 2014 update of the Canadian rheumatology association\/spondyloarthritis research consortium of Canada treatment recommendations for the management of spondyloarthritis. Part II: specific management recommendations. J\u00a0Rheumatol 42(4):665\u2013681","journal-title":"J Rheumatol"},{"issue":"1","key":"1135_CR69","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1136\/annrheumdis-2012-203055","volume":"73","author":"H Haibel","year":"2014","unstructured":"Haibel\u00a0H et al (2014) Efficacy of oral prednisolone in active ankylosing spondylitis: results of a\u00a0double-blind, randomised, placebo-controlled short-term trial. Ann Rheum Dis 73(1):243\u2013246","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"1135_CR70","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12969-020-00435-8","volume":"18","author":"R Chamlati","year":"2020","unstructured":"Chamlati\u00a0R et al (2020) Image guided sacroiliac joint corticosteroid injections in children: an 18-year single-center retrospective study. Pediatr Rheumatol Online J 18(1):52","journal-title":"Pediatr. Rheumatol. Online J."},{"issue":"6","key":"1135_CR71","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1055\/s-2003-39925","volume":"175","author":"T Fischer","year":"2003","unstructured":"Fischer\u00a0T et al (2003) Sacroiliitis in children with spondyloarthropathy: therapeutic effect of CT-guided intra-articular corticosteroid injection. Rofo 175(6):814\u2013821","journal-title":"Rofo"},{"issue":"2","key":"1135_CR72","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0022-3476(95)70320-9","volume":"127","author":"HI Huppertz","year":"1995","unstructured":"Huppertz\u00a0HI et\u00a0al (1995) Intraarticular corticosteroids for chronic arthritis in children: efficacy and effects on cartilage and growth. J\u00a0Pediatr 127(2):317\u2013321","journal-title":"J Pediatr"},{"issue":"11","key":"1135_CR73","first-page":"2696","volume":"27","author":"W Breit","year":"2000","unstructured":"Breit\u00a0W et al (2000) A subgroup-specific evaluation of the efficacy of intraarticular triamcinolone hexacetonide in juvenile chronic arthritis. J\u00a0Rheumatol 27(11):2696\u20132702","journal-title":"J Rheumatol"},{"issue":"10","key":"1135_CR74","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1136\/ard.61.10.941","volume":"61","author":"R Burgos-Vargas","year":"2002","unstructured":"Burgos-Vargas\u00a0R et al (2002) A 26 week randomised, double blind, placebo controlled exploratory study of sulfasalazine in juvenile onset spondyloarthropathies. Ann Rheum Dis 61(10):941\u2013942","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"1135_CR75","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1002\/art.20288","volume":"50","author":"N Ruperto","year":"2004","unstructured":"Ruperto\u00a0N et\u00a0al (2004) A randomized trial of parenteral methotrexate comparing an intermediate dose with a\u00a0higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate. Arthritis Rheum 50(7):2191\u20132201","journal-title":"Arthritis Rheum"},{"key":"1135_CR76","first-page":"CD004524","volume":"2","author":"J Chen","year":"2013","unstructured":"Chen\u00a0J et\u00a0al (2013) Methotrexate for ankylosing spondylitis. Cochrane Database Syst Rev 2:CD4524","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"1135_CR77","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1136\/annrheumdis-2016-210770","volume":"76","author":"D van der Heijde","year":"2017","unstructured":"van der Heijde\u00a0D et al (2017) 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis. Ann Rheum Dis 76(6):978\u2013991","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"1135_CR78","doi-asserted-by":"crossref","first-page":"3798","DOI":"10.1093\/rheumatology\/keaa175","volume":"59","author":"D Poddubnyy","year":"2020","unstructured":"Poddubnyy\u00a0D et\u00a0al (2020) Clinical and imaging characteristics of osteitis condensans ilii as compared with axial spondyloarthritis. Rheumatology (Oxford) 59(12):3798\u20133806","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"1135_CR79","doi-asserted-by":"crossref","first-page":"R230","DOI":"10.1186\/ar4072","volume":"14","author":"G Horneff","year":"2012","unstructured":"Horneff\u00a0G et al (2012) Double-blind, placebo-controlled randomized trial with adalimumab for treatment of juvenile onset ankylosing spondylitis (JoAS): significant short term improvement. Arthritis Res Ther 14(5):R230","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"1135_CR80","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3899\/jrheum.170251","volume":"45","author":"PF Weiss","year":"2018","unstructured":"Weiss\u00a0PF et al (2018) Comparative effectiveness of tumor necrosis factor agents and disease-modifying antirheumatic therapy in children with enthesitis-related arthritis: the first year after diagnosis. J\u00a0Rheumatol 45(1):107\u2013114","journal-title":"J Rheumatol"},{"issue":"17","key":"1135_CR81","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1056\/NEJMoa1614160","volume":"376","author":"AV Ramanan","year":"2017","unstructured":"Ramanan\u00a0AV et\u00a0al (2017) Adalimumab plus methotrexate for uveitis in juvenile idiopathic arthritis. N\u00a0Engl J Med 376(17):1637\u20131646","journal-title":"N Engl J Med"},{"issue":"2","key":"1135_CR82","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1053\/j.gastro.2012.04.046","volume":"143","author":"JS Hyams","year":"2012","unstructured":"Hyams\u00a0JS et\u00a0al (2012) Safety and efficacy of adalimumab for moderate to severe Crohn\u2019s disease in children. Gastroenterology 143(2):365\u2013374.e2","journal-title":"Gastroenterology"},{"issue":"4","key":"1135_CR83","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1002\/art.40750","volume":"71","author":"TJP Bray","year":"2019","unstructured":"Bray\u00a0TJP et\u00a0al (2019) Sacroiliac joint ankylosis in young spondyloarthritis patients receiving biologic therapy: observation of serial magnetic resonance imaging scans. Arthritis Rheumatol 71(4):594\u2013598","journal-title":"Arthritis Rheumatol"},{"issue":"10","key":"1135_CR84","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1136\/annrheumdis-2019-216741","volume":"79","author":"BS Koo","year":"2020","unstructured":"Koo\u00a0BS et al (2020) Tumour necrosis factor inhibitors slow radiographic progression in patients with ankylosing spondylitis: 18-year real-world evidence. Ann Rheum Dis 79(10):1327\u20131332","journal-title":"Ann Rheum Dis"},{"issue":"26","key":"1135_CR85","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1056\/NEJMoa1505066","volume":"373","author":"D Baeten","year":"2015","unstructured":"Baeten\u00a0D et al (2015) Secukinumab, an Interleukin-17A inhibitor, in ankylosing spondylitis. N\u00a0Engl J Med 373(26):2534\u20132548","journal-title":"N Engl J Med"},{"issue":"1","key":"1135_CR86","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1002\/art.41477","volume":"73","author":"A Deodhar","year":"2021","unstructured":"Deodhar\u00a0A et al (2021) Secukinumab improves signs and symptoms of non-radiographic axial spondyloarthritis: primary results of a\u00a0randomized controlled phase III study. Arthritis Rheumatol 73(1):110\u2013120. https:\/\/doi.org\/10.1002\/art.41477","journal-title":"Arthritis Rheumatol"},{"issue":"10163","key":"1135_CR87","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1016\/S0140-6736(18)31946-9","volume":"392","author":"D van der Heijde","year":"2018","unstructured":"van der Heijde\u00a0D et al (2018) Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying anti-rheumatic drugs (COAST-V): 16 week results of a\u00a0phase 3 randomised, double-blind, active-controlled and placebo-controlled trial. Lancet 392(10163):2441\u20132451","journal-title":"Lancet"},{"issue":"10217","key":"1135_CR88","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0140-6736(19)32971-X","volume":"395","author":"A Deodhar","year":"2020","unstructured":"Deodhar\u00a0A et al (2020) Ixekizumab for patients with non-radiographic axial spondyloarthritis (COAST-X): a\u00a0randomised, placebo-controlled trial. Lancet 395(10217):53\u201364","journal-title":"Lancet"},{"issue":"2","key":"1135_CR89","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1136\/annrheumdis-2019-216118","volume":"79","author":"M Dougados","year":"2020","unstructured":"Dougados\u00a0M et al (2020) Efficacy and safety of ixekizumab through 52\u00a0weeks in two phase 3, randomised, controlled clinical trials in patients with active radiographic axial spondyloarthritis (COAST\u2011V and COAST-W). Ann Rheum Dis 79(2):176\u2013185","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"1135_CR90","first-page":"27","volume":"38","author":"S Erdes","year":"2020","unstructured":"Erdes\u00a0S et al (2020) Primary efficacy of netakimab, a\u00a0novel interleukin-17 inhibitor, in the treatment of active ankylosing spondylitis in adults. Clin Exp Rheumatol 38(1):27\u201334","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"1135_CR91","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1136\/annrheumdis-2020-216980","volume":"79","author":"D van der Heijde","year":"2020","unstructured":"van der Heijde\u00a0D et al (2020) Dual neutralisation of interleukin-17A and interleukin-17F with bimekizumab in patients with active ankylosing spondylitis: results from a\u00a048-week phase IIb, randomised, double-blind, placebo-controlled, dose-ranging study. Ann Rheum Dis 79(5):595\u2013604","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"1135_CR92","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s11926-021-01001-1","volume":"23","author":"N Akkoc","year":"2021","unstructured":"Akkoc\u00a0N, Khan\u00a0MA (2021) JAK inhibitors for axial spondyloarthritis: what does the future hold? Curr Rheumatol Rep 23(6):34","journal-title":"Curr Rheumatol Rep"},{"issue":"8","key":"1135_CR93","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1136\/annrheumdis-2016-210322","volume":"76","author":"D van der Heijde","year":"2017","unstructured":"van der Heijde\u00a0D et al (2017) Tofacitinib in patients with ankylosing spondylitis: a\u00a0phase II, 16-week, randomised, placebo-controlled, dose-ranging study. Ann Rheum Dis 76(8):1340\u20131347","journal-title":"Ann Rheum Dis"},{"issue":"10162","key":"1135_CR94","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1016\/S0140-6736(18)32463-2","volume":"392","author":"D van der Heijde","year":"2018","unstructured":"van der Heijde\u00a0D et al (2018) Efficacy and safety of filgotinib, a\u00a0selective Janus kinase 1 inhibitor, in patients with active ankylosing spondylitis (TORTUGA): results from a\u00a0randomised, placebo-controlled, phase 2 trial. Lancet 392(10162):2378\u20132387","journal-title":"Lancet"},{"issue":"10214","key":"1135_CR95","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1016\/S0140-6736(19)32534-6","volume":"394","author":"D van der Heijde","year":"2019","unstructured":"van der Heijde\u00a0D et al (2019) Efficacy and safety of upadacitinib in patients with active ankylosing spondylitis (SELECT-AXIS 1): a\u00a0multicentre, randomised, double-blind, placebo-controlled, phase 2\/3 trial. Lancet 394(10214):2108\u20132117","journal-title":"Lancet"},{"issue":"8","key":"1135_CR96","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1136\/annrheumdis-2020-219601","volume":"80","author":"A Deodhar","year":"2021","unstructured":"Deodhar\u00a0A et al (2021) Tofacitinib for the treatment of ankylosing spondylitis: a\u00a0phase III, randomised, double-blind, placebo-controlled study. Ann Rheum Dis 80(8):1004\u20131013. https:\/\/doi.org\/10.1136\/annrheumdis-2020-219601","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"1135_CR97","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1002\/art.10146","volume":"46","author":"B Flat\u00f8","year":"2002","unstructured":"Flat\u00f8\u00a0B et\u00a0al (2002) The influence of patient characteristics, disease variables, and HLA alleles on the development of radiographically evident sacroiliitis in juvenile idiopathic arthritis. Arthritis Rheum 46(4):986\u2013994","journal-title":"Arthritis Rheum"},{"issue":"10","key":"1135_CR98","first-page":"2055","volume":"35","author":"L Berntson","year":"2008","unstructured":"Berntson\u00a0L et al (2008) HLA-B27 predicts a\u00a0more extended disease with increasing age at onset in boys with juvenile idiopathic arthritis. J\u00a0Rheumatol 35(10):2055\u20132061","journal-title":"J Rheumatol"},{"issue":"2","key":"1135_CR99","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00296-002-0237-4","volume":"23","author":"E Feldtkeller","year":"2003","unstructured":"Feldtkeller\u00a0E et al (2003) Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis. Rheumatol Int 23(2):61\u201366","journal-title":"Rheumatol Int"},{"issue":"2","key":"1135_CR100","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1136\/ard.2007.072512","volume":"67","author":"LS Gensler","year":"2008","unstructured":"Gensler\u00a0LS et al (2008) Clinical, radiographic and functional differences between juvenile-onset and adult-onset ankylosing spondylitis: results from the PSOAS cohort. Ann Rheum Dis 67(2):233\u2013237","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"1135_CR101","first-page":"1780","volume":"29","author":"HJ Baek","year":"2002","unstructured":"Baek\u00a0HJ et\u00a0al (2002) Juvenile onset ankylosing spondylitis (JAS) has less severe spinal disease course than adult onset ankylosing spondylitis (AAS): clinical comparison between JAS and AAS in Korea. J\u00a0Rheumatol 29(8):1780\u20131785","journal-title":"J Rheumatol"},{"issue":"4","key":"1135_CR102","first-page":"668","volume":"34","author":"TJ Kim","year":"2016","unstructured":"Kim\u00a0TJ et\u00a0al (2016) Comparison on radiographic progression for 5\u00a0years between juvenile onset ankylosing spondylitis and adult onset ankylosing spondylitis: an observational study of the Korean SpondyloArthropathy registry (OSKAR) data. Clin Exp Rheumatol 34(4):668\u2013672","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"1135_CR103","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/acr.20460","volume":"63","author":"T Beukelman","year":"2011","unstructured":"Beukelman\u00a0T et\u00a0al (2011) 2011 American college of rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features. Arthritis Care Res (Hoboken) 63(4):465\u2013482","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"7","key":"1135_CR104","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/acr2.11154","volume":"2","author":"PJ Mease","year":"2020","unstructured":"Mease\u00a0PJ et\u00a0al (2020) Characterization of patients with axial spondyloarthritis by enthesitis presence: data from the corrona psoriatic arthritis\/spondyloarthritis registry. ACR Open Rheumatol 2(7):449\u2013456","journal-title":"ACR Open Rheumatol"},{"issue":"6","key":"1135_CR105","first-page":"S16","volume":"20","author":"J Braun","year":"2002","unstructured":"Braun\u00a0J, Pincus\u00a0T (2002) Mortality, course of disease and prognosis of patients with ankylosing spondylitis. Clin Exp Rheumatol 20(6):S16\u201322","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"1135_CR106","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jbspin.2011.02.012","volume":"78","author":"C Prati","year":"2011","unstructured":"Prati\u00a0C et\u00a0al (2011) Mortality in spondylarthritis. Joint Bone Spine 78(5):466\u2013470","journal-title":"Joint Bone Spine"},{"issue":"11","key":"1135_CR107","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1136\/ard.2011.151191","volume":"70","author":"G Bakland","year":"2011","unstructured":"Bakland\u00a0G, Gran\u00a0JT, Nossent\u00a0JC (2011) Increased mortality in ankylosing spondylitis is related to disease activity. Ann Rheum Dis 70(11):1921\u20131925","journal-title":"Ann Rheum Dis"},{"issue":"02","key":"1135_CR108","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1055\/s-0038-1649293","volume":"38","author":"T Hospach","year":"2018","unstructured":"Hospach\u00a0T et al (2018) Protokolle zur Klassifikation, \u00dcberwachung und Therapie in der Kinderrheumatologie (PRO-KIND): Enthesitis-assoziierte Arthritis. Arthritis Rheuma 38(02):132\u2013140. https:\/\/doi.org\/10.1055\/s-0038-1649293","journal-title":"Arthritis Rheuma"},{"key":"1135_CR109","unstructured":"Oommen P et\u00a0al (2019) Therapie der \u201eJuvenilen idiopathischen Arthritis\u201c. https:\/\/www.awmf.org\/leitlinien\/detail\/ll\/027-020.html. Zugegriffen: 28. Juli 2021 (Reg. Nr 027-020)"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-021-01135-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00393-021-01135-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-021-01135-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,4]],"date-time":"2022-02-04T16:48:07Z","timestamp":1643993287000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00393-021-01135-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,5]]},"references-count":109,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["1135"],"URL":"https:\/\/doi.org\/10.1007\/s00393-021-01135-8","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,5]]},"assertion":[{"value":"1 November 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"T.\u00a0Hospach, G.\u00a0Horneff und D.\u00a0Poddubnyy geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patienten zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern eine schriftliche Einwilligung vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}